Increased Tau Expression Correlates With IDH Mutation in Infiltrating Gliomas and Impairs Cell Migration. Issue 5 (19th February 2020)

• Record Type: Journal Article
• Authors: Nakata, Satoshi; Price, Antionette; Eberhart, Charles; Morris, Meaghan
• Is Part Of: Journal of neuropathology and experimental neurology. Volume 79:Issue 5(2020)
• Page Start: 493
• Page End: 499
• Publication Date: 2020-02-19
• Subjects: Astrocytoma -- Glioma -- IDH -- MAPT -- Prognosis -- Tau; Neurology -- Diseases -- Periodicals; Neurology -- Diseases -- Physiopathology -- Periodicals; 616.8047
• DOI: 10.1093/jnen/nlaa013
• Languages: English
• ISSNs: 0022-3069

Abstract

Abstract: Although the microtubule-associated protein tau is well studied in human neurodegeneration, the role of tau in neoplastic brain diseases is not well understood. Recently, studies have shown tau mRNA expression is associated with improved survival in human infiltrating gliomas. However, the biologic basis of this association is largely unexplored. Using 2 independent publicly available mRNA databases, we show that high tau mRNA expression is associated with improved patient survival in infiltrating gliomas. Higher tau protein expression is also associated with improved patient prognosis in infiltrating gliomas by immunohistochemical staining of tissue microarrays. This prognostic association is in part due to higher tau mRNA and protein expression in IDH-mutant infiltrating astrocytomas. Expression of tau in an IDH-wildtype glioblastoma cell line selectively impairs cell migration in assays designed to mimic tumor invasion. These findings suggest that tau expression is not only associated with IDH mutation status but also may contribute to improved patient outcomes by impairing tumor invasion.